Smith & Nephew shares rise on confirmed full year outlook
First-quarter sales miss forecastsFull-year growth and margins confirmedStrong growth from emerging marketsSmith & Nephew (SN.) topped the FTSE gainers on Wednesday, rising 3.4% to £10.16 despite medical equipment maker missing first quarter sales estimates due to soft trading in its Advanced Wound Management franchise.Year-to-date the shares continue to lag the FTSE 100, falling 5% compared with